|
Pharma's
Rx for 2009
As the global economic meltdown unfolds, there will be more
casualties to report. And with Indian pharma till now mimicking
the moves of the global pharma industry, what new prescription
do industry veterans suggest? Arshiya Khan gives a low-down
The
'IT' factor
Importance of information technology (IT) has no bounds in
today's technology savvy world. But how far has IT permeated
the Indian pharmaceutical sector? Suja Nair explores
Blocked
in transit
As aggressive IP enforcement continues at the hands of EU
ports, should goods in transit be protected when they are
without a doubt intended for markets where their use is legitimate?
Aashruti Kak surveys the complications involved
Drugs
from the deep
As pharmaceutical companies face drying pipelines, the ocean
is turning out to be a treasure trove of pharmacologically
active leads. Viveka Roychowdhury skims through some promising
leads and stumbling blocks
Packaging
Special
Definitely
not child's play
Children are naturally attracted to brightly coloured medication
and it only takes a second to pop a pill, but this innocent
act could lead to tragedy. Child resistant packaging is one
optimum solution to this situation. Usha Sharma traces a new
trend in the industry.
Pharma Technology
Review
Playing
safe
Though advances in technology and research have speeded up
the drug discovery process, safety of workers at drug manufacturing
units should also be taken care of. Sachin Jagdale reports
What
lies ahead?
After acquiring a special position in the market with their
'branded products', big pharma companies are in danger of
losing their coveted post due to patent expiries, especially
since there are few new products which match up to their predecessors'
repute. What next? Suja Nair maps the next moves
Lab Next
Next
generation GLP guidelines
The mandatory Good Laboratory Practices (GLP) guidelines can
be viewed as both threat and opportunity. But industry players
too realise that its high time they moved to the next level.
Usha Sharma analyses
|
